Lung cancer (Amsterdam, Netherlands), 2014-11, Vol.86 (2), p.133-136
2014
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials
- Ist Teil von
- Lung cancer (Amsterdam, Netherlands), 2014-11, Vol.86 (2), p.133-136
- Ort / Verlag
- Oxford: Elsevier Ireland Ltd
- Erscheinungsjahr
- 2014
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Highlights • We compared overall response rates by subtypes in mesothelioma. • In a systematic review of 30 trials, 21.9% of patients responded to therapy. • In comparison, only 13.9% of patients with sarcomatoid subtypes responded. • Responses rates by subtypes of mesothelioma are infrequently reported. • Post hoc analysis of cisplatin–pemetrexed trial by subtype included.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0169-5002eISSN: 1872-8332DOI: 10.1016/j.lungcan.2014.08.017Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4254081
- Format
- –
- Schlagworte
- Biological and medical sciences, Clinical Trials as Topic, Combined Modality Therapy, Epithelioid, Hematology, Oncology and Palliative Medicine, Humans, Lung Neoplasms - therapy, Medical sciences, Mesothelioma, Mesothelioma - therapy, Mesothelioma, Malignant, Multiple tumors. Solid tumors. Tumors in childhood (general aspects), Pleural Neoplasms - therapy, Pneumology, Pulmonary/Respiratory, Response rates, Sarcomatoid, Systematic review, Treatment Outcome, Tumor, Tumors, Tumors of the respiratory system and mediastinum